Private equity firm Kester Capital has acquired Hitchin, Hertfordshire-based EMAS Pharma, the clinical development division ...

Enanta's oral N-protein inhibitor zelicapavir showed positive Phase 2 results in pediatric RSV. Carisma Therapeutics announces 34% workforce reduction. Innovent Biologics reports promising data for ...

Kester Capital (“Kester”), a leading UK private equity investor focused on the life sciences and technology sectors, alongside a new senior management team, has acquired EMAS Pharma (“EMAS”) (“the ...

UK-based private equity firm Kester Capital has acquired EMAS Pharma, the clinical development division of Bionical Emas, ...

Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...

You are unauthorized to view this page. Hamberley Care Homes has signed a 30-year lease deal with Belgian healthcare real estate investment trust Aedifica’s UK division for a new luxury care home site ...